{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:37:24Z","timestamp":1793389044761,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03986-2","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:23:49Z","timestamp":1762874629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Time to sputum culture conversion and associated factors in multidrug-resistant tuberculosis patients in Southwestern Oromia, Ethiopia: a ten-year retrospective follow-up study"],"prefix":"10.1186","volume":"25","author":[{"given":"Getu","family":"Balay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zegeye","family":"Bonsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eba","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gari","family":"Abeba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endashaw","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulualem","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakjira","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemeda","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"3986_CR1","unstructured":"World Health Organization. WHO consolidated operational handbook on tuberculosis: module 4: treatment and care . World Health Organization. 2025; 35. Available from: https:\/\/iris.who.int\/handle\/10665\/381095."},{"key":"3986_CR2","unstructured":"World Health Organization. Global Tuberculosis Report 2023. World Health Organization. 2023. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/373828\/9789240083851-eng.pdf?sequence=1."},{"key":"3986_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270272","author":"KA Molla","year":"2022","unstructured":"Molla KA, Reta MA, Ayene YY. Prevalence of multidrug-resistant tuberculosis in East Africa: a systematic review and meta-analysis. PLoS ONE. 2022. https:\/\/doi.org\/10.1371\/journal.pone.0270272.","journal-title":"PLoS ONE"},{"key":"3986_CR4","doi-asserted-by":"publisher","unstructured":"Abdella K, Abdissa K, Kebede W, Abebe G. Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia. BMC Public Health. 2015;15(1):1\u20137. Available from: https:\/\/doi.org\/10.1186\/s12889-015-1955-3.","DOI":"10.1186\/s12889-015-1955-3"},{"key":"3986_CR5","unstructured":"WHO consolidated guidelines on tuberculosis Module 4: Treatment Drug-resistant tuberculosis treatment Module 4: Treatment WHO operational handbook on tuberculosis Drug-resistant tuberculosis treatment. 2020. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240007048."},{"key":"3986_CR6","unstructured":"EFMoH. Guidelines for clinical and programmatic management of TB, TB \/ HIV, DR-TB and leprosy in Ethiopia. Vol. 6. 2021;1\u2013249. http:\/\/repository.iphce.org\/handle\/123456789\/3807."},{"issue":"3","key":"3986_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S2213-2600(15)00036-3","volume":"3","author":"EV Kurbatova","year":"2015","unstructured":"Kurbatova EV, Cegielski JP, Lienhardt C, Akksilp R, Bayona J, Becerra MC, et al. Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies. Lancet Respir Med. 2015;3(3):201\u20139. https:\/\/doi.org\/10.1016\/S2213-2600(15)00036-3.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"3986_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1371\/journal.pone.0093206","volume":"9","author":"A Basit","year":"2014","unstructured":"Basit A, Ahmad N, Khan AH, Javaid A, Syed Sulaiman SA, Afridi AK, et al. Predictors of two months culture conversion in multidrug-resistant tuberculosis: findings from a retrospective cohort study. PLoS ONE. 2014;9(4):5\u201310.","journal-title":"PLoS ONE"},{"issue":"4","key":"3986_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.5588\/ijtld.12.0481","volume":"17","author":"M Rodriguez","year":"2013","unstructured":"Rodriguez M, Monedero I, Caminero JA, Encarnaci\u00f3n M, Dominguez Y, Acosta I, et al. Successful management of multidrug-resistant tuberculosis under programme conditions in the Dominican Republic. Int J Tuberc Lung Dis. 2013;17(4):520\u20135.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"3986_CR10","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1164\/rccm.202107-1779OC","volume":"205","author":"A Esmail","year":"2022","unstructured":"Esmail A, Oelofse S, Lombard C, Perumal R, Mbuthini L, Mahomed AG, et al. An all-oral 6-month regimen for Multidrug-Resistant tuberculosis a multicenter, randomized controlled clinical trial (the next study). Am J Respir Crit Care Med. 2022;205(10):1214\u201327.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3986_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0198080","volume":"13","author":"A Shibabaw","year":"2018","unstructured":"Shibabaw A, Gelaw B, Wang SH, Tessema B. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar hospital, Northwest Ethiopia. PLoS One. 2018;13(6):1\u201315.","journal-title":"PLoS One"},{"key":"3986_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijid.2020.06.029","volume":"98","author":"MA Assemie","year":"2020","unstructured":"Assemie MA, Alene M, Petrucka P, Leshargie CT, Ketema DB. Time to sputum culture conversion and its associated factors among multidrug-resistant tuberculosis patients in Eastern Africa: a systematic review and meta-analysis. Int J Infect Dis. 2020;98:230\u20136. https:\/\/doi.org\/10.1016\/j.ijid.2020.06.029.","journal-title":"Int J Infect Dis"},{"key":"3986_CR13","doi-asserted-by":"publisher","unstructured":"Abebe M, Atnafu A, Tilahun M, Sero N, Neway S, Alemu M et al. Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study. PLoS One. 2024;19(5):1\u201312. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0304507","DOI":"10.1371\/journal.pone.0304507"},{"key":"3986_CR14","doi-asserted-by":"publisher","unstructured":"Kumar G, Muni MKS, Kumar R, Kumar MSR. NK. Study of culture conversion in drug\u2013resistant pulmonary tuberculosis on all\u2013oral longer regimen at IGIMS, Patna. J Pharm Bioallied Sci. 2024;S1549\u201353. https:\/\/doi.org\/10.4103\/jpbs.jpbs_407_23.","DOI":"10.4103\/jpbs.jpbs_407_23"},{"key":"3986_CR15","unstructured":"Federal Democratic Republic of Ethiopia, Ministry of Health. National guidelines for management of TB, DR-TB and leprosy in ethiopia sixth edition. 2017;6:1\u201314.\u00a0https:\/\/www.afro.who.int\/publications\/national-guidelines-tb-drug-resistant-tb-and-leprosy-ethiopia-sixth-edition."},{"key":"3986_CR16","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.2147\/IDR.S250878","volume":"13","author":"Y Tekalegn","year":"2020","unstructured":"Tekalegn Y, Woldeyohannes D, Assefa T, Aman R, Sahiledengle B. Predictors of time to sputum culture conversion among drug-resistant tuberculosis patients in Oromia region hospitals, Ethiopia. Infect Drug Resist. 2020;13:2547\u201356.","journal-title":"Infect Drug Resist"},{"issue":"May","key":"3986_CR17","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.2147\/IDR.S413495","volume":"16","author":"L Weldemhret","year":"2023","unstructured":"Weldemhret L, Atsbaha AH, Legesse HBL, Kahsay AG, Hagos D, Desta A. Time to sputum culture conversion and its predictors among multidrug resistant tuberculosis patients in Tigray, Northern ethiopia: retrospective cohort study. Infect Drug Resist. 2023;16(May):3671\u201381.","journal-title":"Infect Drug Resist"},{"key":"3986_CR18","doi-asserted-by":"publisher","unstructured":"Wenlu Y, Xia Z, Chuntao W, Qiaolin Y, Xujue X, Rong Y et al. Time to sputum culture conversion and its associated factors among drug-resistant tuberculosis patients: a systematic review and meta-analysis. BMC Infect Dis. 2024;24(1):1\u201313. Available from: https:\/\/doi.org\/10.1186\/s12879-024-09009-5","DOI":"10.1186\/s12879-024-09009-5"},{"issue":"1","key":"3986_CR19","first-page":"1","volume":"34","author":"R Ncha","year":"2019","unstructured":"Ncha R, Variava E, Otwombe K, Kawonga M, Martinson NA. Predictors of time to sputum culture conversion in multi-drug-resistant tuberculosis and extensively drug-resistant tuberculosis in patients at Tshepong-Klerksdorp hospital. South Afr J Infect Dis. 2019;34(1):1\u20138.","journal-title":"South Afr J Infect Dis"},{"key":"3986_CR20","first-page":"1","volume":"65","author":"TY Akalu","year":"2018","unstructured":"Akalu TY, Muchie KF, Gelaye KA. Time to sputum culture conversion and its determinants among Multi-drug resistant tuberculosis patients at public hospitals of the Amhara regional state: A multicenter retrospective follow up study. PLoS ONE. 2018;65:1\u201314.","journal-title":"PLoS ONE"},{"issue":"1","key":"3986_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3021-0","volume":"18","author":"Q Liu","year":"2018","unstructured":"Liu Q, Lu P, Martinez L, Yang H, Lu W, Ding X, et al. Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China. BMC Infect Dis. 2018;18(1):1\u20137.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"3986_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0142607","volume":"10","author":"R Kanda","year":"2015","unstructured":"Kanda R, Nagao T, Van Tho N, Ogawa E, Murakami Y, Osawa M, et al. Factors affecting time to sputum culture conversion in adults with pulmonary tuberculosis: A historical cohort study without censored cases. PLoS ONE. 2015;10(11):1\u20139.","journal-title":"PLoS ONE"},{"issue":"2","key":"3986_CR23","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1183\/09031936.00007410","volume":"37","author":"WJ Su","year":"2011","unstructured":"Su WJ, Feng JY, Chiu YC, Huang SFLY. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis. Eur Respir J. 2011;37(2):376\u201383.","journal-title":"Eur Respir J"},{"key":"3986_CR24","doi-asserted-by":"publisher","unstructured":"Russkikh A, Korotych O, Sereda Y, Samoilova A, Achar J, Yedilbayev A, Dara MVI. Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018\u20132019 in the Russian federation: an observational cohort study. Monaldi Arch Chest Dis. 2021;91(1)63\u201371. https:\/\/doi.org\/10.4081\/monaldi.2021.1678.","DOI":"10.4081\/monaldi.2021.1678"},{"issue":"340","key":"3986_CR25","first-page":"6","volume":"115","author":"MH Aliyu","year":"2003","unstructured":"Aliyu MH, Salihu HMRR. HIV infection and sputum-culture conversion in patients diagnosed with Mycobacterium tuberculosis: a population-based study. Wien Klin Wochenschr. 2003;115(340):6.","journal-title":"Wien Klin Wochenschr"},{"key":"3986_CR26","unstructured":"Salihu HM, Aliyu MH, Ratard RPLB. Characteristics associated with reported sputum culture conversion in the era of re-emergent mycobacterium tuberculosis in the state of North Carolina, 1993\u20131998. Int J Tuberc Lung Dis. 2003;7(11):1070\u20136."},{"key":"3986_CR27","doi-asserted-by":"publisher","unstructured":"Karnan A et al. A Comprehensive Review on Long Vs. Short Regimens in Multidrug-Resistant Tuberculosis (MDR-TB) Under Programmatic Management of Drug-Resistant Tuberculosis (PMDT). Cureus. 2023;16(1). Available from: https:\/\/doi.org\/10.7759\/cureus.52706","DOI":"10.7759\/cureus.52706"},{"key":"3986_CR28","unstructured":"World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update. Geneva: World Health Organization; 2016.\u00a0https:\/\/www.who.int\/publications\/i\/item\/9789241549639."},{"key":"3986_CR29","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00061-2017","author":"F Ahmad Khan","year":"2017","unstructured":"Ahmad Khan F, et al. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.00061-2017.","journal-title":"Eur Respir J"},{"key":"3986_CR30","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0028-2023","author":"F Saluzzo","year":"2023","unstructured":"Saluzzo F, Adepoju VA, Duarte R, Lange C. Treatment-shortening regimens for tuberculosis: updates and future priorities. Breathe. 2023. https:\/\/doi.org\/10.1183\/20734735.0028-2023.","journal-title":"Breathe"},{"issue":"6","key":"3986_CR31","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/jac\/dki376","volume":"56","author":"SH Gillespie","year":"2005","unstructured":"Gillespie SH, Gosling RD, Uiso L, Sam NE, Kanduma EGMT. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis. J Antimicrob Chemother. 2005;56(6):1169\u201371.","journal-title":"J Antimicrob Chemother"},{"issue":"13","key":"3986_CR32","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1811867","volume":"380","author":"AJ Nunn","year":"2019","unstructured":"Nunn AJ, Phillips PP, Meredith SK, Chiang CY, Conradie F, Dalai D, et al. A trial of a shorter regimen for rifampin-resistant tuberculosis. N Engl J Med. 2019;380(13):1201\u201313.","journal-title":"N Engl J Med"},{"key":"3986_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197880","author":"KA Alene","year":"2018","unstructured":"Alene KA, et al. Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis. PLoS One. 2018. https:\/\/doi.org\/10.1371\/journal.pone.0197880.","journal-title":"PLoS One"},{"key":"3986_CR34","doi-asserted-by":"publisher","unstructured":"Abubakar M, Ahmad N, Atif M, Ahmad I, Wahid A, Khan A et al. Prognostic accuracy of time to sputum culture conversion in predicting cure in extensively drug-resistant tuberculosis patients: a multicentre retrospective observational study. BMC Infect Dis. 2022;22(1):1\u201312. Available from: https:\/\/doi.org\/10.1186\/s12879-022-07202-y","DOI":"10.1186\/s12879-022-07202-y"},{"key":"3986_CR35","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01558-2016","author":"P Lu","year":"2017","unstructured":"Lu P, Liu Q, Martinez L, Yang H, Lu W, Ding X, et al. Time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis: a prospective cohort study from urban China. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.01558-2016.","journal-title":"Eur Respir J"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03986-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03986-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03986-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:23:55Z","timestamp":1762874635000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03986-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3986"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03986-2","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted following the principles stated in the Declaration of Helsinki. The study protocol was approved by the Institutional Review Board (IRB) of the Institute of Health of Jimma University, Ethiopia (Reference: IHRPGn\/168\/21). Moreover, official permission was also obtained from all study sites. Since the study was retrospective and did not involve any personally identifiable information, the ethical committee waived the requirement for informed consent. To protect the privacy and confidentiality of the participants, patient names and identification numbers were not extracted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"518"}}